Additionally, Kaplan-Meier survival analysis of clinical data showed that expressions of METTL3 and MALAT1 were inversely correlated with BC patients’ survival, and survival analysis of clinical data showed that the high expression of METTL3 and MALAT1 were always evident in patients with poor survival (Fig. 1I). The gene discussed is MALAT1; the disease is breast cancer.